138300-83-1

Basic information

• Product Name: Acetamide, N-[(4-hydroxy-1-methyl-4-piperidinyl)methyl]-
• Synonyms: Acetamide, N-[(4-hydroxy-1-methyl-4-piperidinyl)methyl]-
• CAS NO: 138300-83-1
• Molecular Formula: C9H18N2O2
• Molecular Weight: 0
• Mol File: 138300-83-1.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Acetamide, N-[(4-hydroxy-1-methyl-4-piperidinyl)methyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Acetamide, N-[(4-hydroxy-1-methyl-4-piperidinyl)methyl]-(138300-83-1)
• EPA Substance Registry System: Acetamide, N-[(4-hydroxy-1-methyl-4-piperidinyl)methyl]-(138300-83-1)

Safety Data

• Hazardous Substances Data: 138300-83-1(Hazardous Substances Data)

Upstream product

• 26228-68-2 4-aminomethyl-4-hydroxy-1-methylpiperidine 

Relevant articles and documents

AZA SPIRO COMPOUNDS ACTING ON THE CHOLINERGIC SYSTEM WITH MUSCARINIC AGONIST ACTIVITY

Compounds useful for treating diseases of the central or peripheral nervous system in mammals have formulae I-XII STR1 wherein ring A or A' together with the spiro-carbon atom constitutes a bridged or unbridged ring containing one or two ring nitrogen atoms; and the other symbols have specified values, subject to certain conditions.

Spiro compounds containing five-membered rings

Compounds useful for treating diseases of the central or peripheral nervous system in mammals have formulae I-XIII: STR1 wherein ring A or A' together with the spiro-carbon atom constitutes a bridged or unbridged ring containing one or two ring nitrogen atoms; and the other symbols have specified values, subject to certain conditions.

Fused aromatic-spiropiperidine oxazepinones(and thiones)

Novel aromatic-spiropiperidineoxazepinones and thiones exhibiting antihistamine activity are disclosed having the formula: STR1 wherein A represents an aromatic ring, selected from benzo when Z is carbon or pyrido[3,2-f] when Z is nitrogen either of which rings may be optionally substituted on carbon; B is selected from oxygen or sulfur; R1 is selected from the group consisting of loweralkyl, cycloalkyl, cycloalkyl-loweralkyl or phenyl-loweralkyl of which phenyl may be optionally substituted; R is selected from the group consisting of loweralkyl, cycloalkyl or phenyl-loweralkyl of which phenyl may be optionally substituted and the pharmaceutically acceptable salts thereof and novel chemical intermediates in the preparation thereof.